Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 55/100

Failure Rate

16.7%

1 terminated/withdrawn out of 6 trials

Success Rate

66.7%

-19.8% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

100%

2 of 2 completed trials have results

Key Signals

1 recruiting2 with results

Enrollment Performance

Analytics

N/A
3(60.0%)
Phase 1
1(20.0%)
Phase 2
1(20.0%)
5Total
N/A(3)
Phase 1(1)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT07244549Recruiting

Chronic Outcome Monitoring for DBS in Dystonia

Role: collaborator

NCT04916444Not ApplicableCompleted

Dystonia Treatment With Injections Supplemented By Transcranial Magnetic Stimulation

Role: collaborator

NCT02837185Not ApplicableTerminated

Effects of Botulinum Toxin on Muscle and Brain Activity

Role: collaborator

NCT01884064Phase 1Completed

Repetitive Transcranial Magnetic Stimulation for the Treatment of Focal Hand Dystonia

Role: collaborator

NCT00418925Phase 2Unknown

Efficacy of Dronabinol for the Treatment of Cervical Dystonia

Role: collaborator

NCT00579033Not ApplicableUnknown

Somatosensory Processing in Focal Hand Dystonia

Role: collaborator

All 6 trials loaded